Keywords: ph, ii, data, texas, novastan, acute, mi

Ph II Data With Texas' Novastan In Acute MI

Article | 07 April 1997

Print This

Texas Biotechnology has reported promising Phase II data from two trialswith Novastan (argatroban for injection), as an adjunctive therapy to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in